The single-dose shot from Pfizer, known as Abrysvo, has already been approved by the Food and Drug Administration. It stimulates the production of antibodies in pregnant women, which are then passed through the placenta.Original Article
CDC Recommends RSV Vaccine During Pregnancy To Protect Infants: Everything You Need To Know
